Hong Kong firm invests in Jena-based Oncgnostics GmbH

12-Sep-2023 - The Hong Kong-based company Grande Bio-tech Co. Ltd. is making a seven-digit Euros investment in the Jena-based diagnostic company Oncgnostics GmbH. Oncgnostics has developed the cancer diagnostic Gyntect for the reliable detection of cervical cancer. Since 2022, this test has also been ...

Cancer screening from home?

Detection with independently taken samples can work

12-Aug-2021 - A large proportion of women who develop cervical cancer in high-income countries such as Germany do not regularly attend screening. This is particularly alarming, as cancer screenings have become much less frequent since the onset of the corona pandemic. A study by Hannover Medical School and the ...

HPV may lurk in your throat

02-Feb-2018 - Human papilloma virus (HPV), the culprit behind cervical cancer and some forms of head and neck cancer may hide in small pockets on the surface of tonsils in people not known to carry the virus. The finding, reported by University of Rochester Medical Center researchers, could be pivotal for the ...

By decoding how HPV causes cancer, researchers find a new potential treatment strategy

04-Oct-2017 - A study that teases apart the biological mechanisms by which human papillomaviruses (HPV) cause cancer has found what researchers at Georgetown University Medical Center say is a new strategy that might provide targeted treatment for these cancers. HPV is responsible for the majority of cervical ...

Tiny nanoparticles offer significant potential in detecting and treating disease

New review of work on exosomes

26-Jun-2017 - Exosomes - tiny biological nanoparticles which transfer information between cells - offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded. Areas which could benefit include cancer treatment and regenerative ...

Metabolic pathway that drives tumor growth in aggressive cancers

03-Mar-2017 - Mount Sinai researchers have discovered that a rheumatoid arthritis drug can block a metabolic pathway that occurs in tumors with a common cancer-causing gene mutation, offering a new possible therapy for aggressive cancers with few therapeutic options, according to a study to be published in ...

Nanomotors are controlled, for the first time, inside living cells

12-Feb-2014 - For the first time, a team of chemists and engineers at Penn State University have placed tiny synthetic motors inside live human cells, propelled them with ultrasonic waves and steered them magnetically. It's not exactly "Fantastic Voyage," but it's close. The nanomotors, which are rocket-shaped ...

Oncgnostics GmbH obtains seed funding for financing preclinical and clinical trials

High-Tech Gründerfonds and STIFT invest into molecular cancer diagnostics from Jena

19-Apr-2012 - Chemical alterations of the genetic information specifically occuring during carcinogenesis provide the basis for the innovative diagnostic tests that are developed by the newly established oncgnostics GmbH in Jena. These tests allow not only for an earlier, but also a more accurate detection of ...

FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer

21-Apr-2011 - Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions about patient care, which may prevent ...

p16 Immuno-cytochemistry shows superior clinical performance to HPV testing

23-Jun-2010 - mtm laboratories announced the publication of a large study in the American Journal of Clinical Pathology that evaluated the clinical performance of the CE-labeled CINtec® Cytology kit in managing equivocal or mildly abnormal cytologic results. The publication authored by Denton and colleagues ...